| 抗肿瘤药物导致的心血管并发症 |
| |
| 引用本文： | 陈元美,吴士尧,胡钧培. 抗肿瘤药物导致的心血管并发症[J]. 上海交通大学学报(医学版), 2008, 28(12): 1594-1597 |
| |
| 作者姓名： | 陈元美 吴士尧 胡钧培 |
| |
| 作者单位： | [1]上海交通大学医学院第九人民医院心内科,上海200011 [2]上海交通大学医学院第九人民医院血液科,上海200011 |
| |
| 摘 要： | 许多临床常用的抗肿瘤药物都有不同程度的心脏毒性。抗肿瘤药物导致心脏毒性的危险因素是多方面的，常见的心血管并发症包括心力衰竭、缺血、高血压、低血压、水肿、QT延长、胸腔积液或心包积液、心动缓慢及血栓形成等。化疗前后有必要对左室心功能进行监测，并采取有效措施保护心肌。
|
| 关 键 词： | 化疗 心力衰竭 心律失常 血栓形成 监测 保护 |
Cardiovascular complications induced by chemotherapeutic agents |
| |
| CHEN Yuan-mei,WU Shi-yao,HU Jun-pei. Cardiovascular complications induced by chemotherapeutic agents[J]. Journal of Shanghai Jiaotong University:Medical Science, 2008, 28(12): 1594-1597 |
| |
| Authors: | CHEN Yuan-mei WU Shi-yao HU Jun-pei |
| |
| Affiliation: | 1.Department of Cardiology;2.Department of Hematology;The Ninth's People Hospital;School of Medicine;Shanghai Jiaotong University;Shanghai 200011;China |
| |
| Abstract: | Cardiac toxicity is found in frequently used chemotherapeutic agents.There are many factors related to the cardiac toxicity caused by chemotherapeutic agents.The common cardiovascular complications include heart failure,ischemia,hypertension,hypotension,edema,QT prolongation,pleural effusion,pericardial effusion,bradyarrhythmia and thromboembolism.It is necessary to monitor the left ventricular function before and after chemotherapy and take effective measures to protect myocardium. |
| |
| Keywords: | chemotherapy heart failure arrhythmia thromboembolism monitoring protection |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
